| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/20/2013 | CN102939081A Therapeutic regimen and method for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency |
| 02/20/2013 | CN102935162A Pills for retrobulbar neuritis and preparation method |
| 02/20/2013 | CN102935117A Traditional Chinese medicine composition for soothing liver and improving eyesight |
| 02/20/2013 | CN102935112A Traditional Chinese medicine for treating acute and chronic otitis media suppurative |
| 02/20/2013 | CN102935103A Preparation method for effervescent tablet containing pueraria mirifica flavone |
| 02/20/2013 | CN102240357B Medicament for treating tinnitus and preparation method thereof |
| 02/19/2013 | US8377982 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | US20130041019 SDF-1 Binding Nucleic Acids |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130041002 Denibulin di-hydrochloride |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040974 Piperidine inhibitors of janus kinase 3 |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040960 Ophthalmic gel of gatifloxacin and preparation method thereof |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040896 Methods and compositions for modulating angiogenesis and pericyte composition |
| 02/14/2013 | US20130040895 Pharmaceutical Formulations and Methods for Treating Ocular Conditions |
| 02/14/2013 | US20130039971 Compositions and methods for inhibition of vegf |
| 02/14/2013 | US20130039928 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 02/14/2013 | US20130039924 Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039879 Ophthalmic Compositions Containing A Synergistic Combination Of Two Polymers |
| 02/13/2013 | EP2555780A1 Gamma-polyglutamic acid-based ocular irrigating solutions |
| 02/13/2013 | EP2555776A1 Combination compositions of adenosine a1 agonists and non-selective beta-adrenergic receptor blockers for reducing intraocular pressure |
| 02/13/2013 | EP2555775A1 Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure |
| 02/13/2013 | EP2555771A1 Pharmaceutical compositions highly dosed with biotin |
| 02/13/2013 | EP2555770A1 Ketorolac compositions for corneal wound healing |
| 02/13/2013 | CN102933593A Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| 02/13/2013 | CN102933559A Optically active dibenzylamine derivative, and manufacturing method for same |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102933220A Combination compositions of adenosine a1 agonists and carbonic anhydrase inhibitors for reducing intraocular pressure |
| 02/13/2013 | CN102924573A Actin binding peptide and purpose thereof |
| 02/13/2013 | CN102920947A Pharmaceutical composition for relieving eyestrain and preparation method of pharmaceutical composition |
| 02/13/2013 | CN102920911A Chinese medicament for treating keratoconjunctivitis sicca and preparation method thereof |
| 02/13/2013 | CN102920893A Fifteen-component alplily eyesight improving tablet and preparation process thereof |
| 02/13/2013 | CN102920845A Traditional Chinese medicine composition for treating fundus macular degeneration and preparation method of traditional Chinese medicine composition |
| 02/13/2013 | CN102920763A Lutein ester enteric microcapsule and preparation method thereof |
| 02/13/2013 | CN102920722A Ophthalmic preparation for treating fundus diseases |
| 02/13/2013 | CN102920698A Composition for ophthalmic disease associated with hypoxia or ischemia |
| 02/13/2013 | CN102920685A Lysozyme film agent for eyes and preparation method thereof |
| 02/13/2013 | CN102920237A Antibacterial health-care pillow |
| 02/13/2013 | CN101721468B Method for preparing salvianolic acids |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372401 Human antibodies that bind human TNFα |
| 02/12/2013 | US8372400 Methods of treating disorders using human antibodies that bind human TNFα |
| 02/12/2013 | CA2468892C Vitamin d analogues |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/07/2013 | WO2013019966A1 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | WO2013019548A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | WO2013018804A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | WO2013017821A1 Pharmaceutical composition comprising ebastine and fluticasone |
| 02/07/2013 | WO2012174243A8 D -serine for the treatment of visual system disorders |
| 02/07/2013 | US20130035392 Selective inhibition of the membrane attack complex of complement and C3 convertase by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
| 02/07/2013 | US20130035388 Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex |
| 02/07/2013 | US20130035368 Oligonucleotide compounds comprising non-nucleotide overhangs |
| 02/07/2013 | US20130035367 Antisense oligonucleotides that target a cryptic splice site in ush1c as a therapeutic for usher syndrome |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035358 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035345 Solid dispersion formulations and methods of use thereof |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035309 Ophthalmic sealant composition and method for use |
| 02/07/2013 | US20130035281 Pharmaceutical composition, methods for treating and uses thereof |
| 02/07/2013 | US20130034606 Immediate release tablet formulations |
| 02/07/2013 | US20130034588 Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof |
| 02/07/2013 | US20130034555 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases |
| 02/07/2013 | US20130034550 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 02/07/2013 | US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2842954A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders |
| 02/07/2013 | CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/07/2013 | CA2841644A1 Pharmaceutical composition comprising ebastine and fluticasone |
| 02/06/2013 | EP2554175A1 Composition for treatment of damaged part |
| 02/06/2013 | EP2552965A2 Anti-cd40 antibodies |
| 02/06/2013 | EP2552940A2 Peptides for promoting angiogenesis and an use thereof |
| 02/06/2013 | EP2552932A1 Adenosine compounds and their use thereof |
| 02/06/2013 | EP2552456A1 Sirna therapy for transthyretin (ttr) related ocular amyloidosis |
| 02/06/2013 | CN102918157A SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| 02/06/2013 | CN102918063A Anti-cd40 antibodies |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102908604A Bighead atractylodes rhizome and gastrodia tuer capsules |
| 02/06/2013 | CN102908554A Traditional Chinese medicine composition for treating squamous blepharitis |
| 02/06/2013 | CN102908534A Chinese medicinal composition for treating myopia, strabismus and astigmatism of youngsters and preparation process |
| 02/06/2013 | CN102908499A Traditional Chinese medicine composition for treating acute scleritis |
| 02/06/2013 | CN102908460A Oolong tea throat lozenge and preparation method thereof |
| 02/06/2013 | CN102908409A Production process of Chinese rhubarb fine powder granules |
| 02/06/2013 | CN102908390A Preparation method of Fructus Schisandrae/indigo honeysuckle oral liquid containing crude polysaccharides |
| 02/06/2013 | CN102908363A Deproteinized calf blood extract and preparation process thereof |
| 02/06/2013 | CN102146074B Preparation method of pyrrole derivative and application thereof |
| 02/05/2013 | US8367664 Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors |